Dr. Leana Wen, a health news commentator for The Washington Post and CNN, is known for trying to have an open view toward untraditional opinions. For instance, she tells “Conversations on Health Care” that the new National Institutes of Health and Food and Drug Administration directors are both “qualified individuals who have credentials from major medical institutions, who have worked in those fields.”

She says her hope is that “behind the scenes they will act as tempering force… against the worse excesses around …Robert F. Kennedy, Jr. and vaccine policy.”

But she also tells hosts Mark Masselli and Margaret Flinter that “Of course, this is an extremely worrisome time… many of the changes we’re seeing are even more extreme than may have been anticipated.”

In addition, Dr. Wen urges nuance in evaluating public health claims. “It’s important for us to evaluate each of these claims separately… and not have a knee-jerk reaction to everything [Kennedy] says.”

This episode dives into the politics of vaccines, the measles outbreak, food additives, artificial intelligence in medicine, and the evolving role of trust in public health.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Very early this morning the U.S. House passed a bill that would result in more than 7 million people losing Medicaid coverage if it became law; that estimate is from the Congressional Budget Office.

As the bill was coming together, the chief Washington correspondent for KFF Health News shared her analysis. Julie Rovner highlighted that to get a bill across the finish line was going to require overcoming the skepticism of some politicians. “There’s a growing group of Republicans who are unhappy with how many reductions there are to the Medicaid program… including people who voted for the Republican [Party] and President Trump,” she said.

Rovner also reviewed the Trump administration’s efforts to ignore congressional appropriations and other laws. “As I say, this administration… is not following the law” and Rovner explained how that threatens the country’s public health.

From the future of Medicaid and food assistance to questions about accountability and health infrastructure, this conversation offers crucial insights into the latest health policy flashpoints with hosts Mark Masselli and Margaret Flinter.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Millions are still living with the effects of Long COVID and new research shows that for older adults, the consequences may be profound and lasting.

In part one of a special two-part series on “Conversations on Health Care,” Dr. Gabriel de Erausquin, a neurologist and leading Long COVID researcher at the University of Texas Health San Antonio, shares groundbreaking findings from his global study of over 3,500 patients. His work reveals a troubling connection: many Long COVID patients over 60 show cognitive decline that mirrors early signs of dementia.

“The parts of the brain that are affected by COVID overlap significantly with those that are affected early in the course of Alzheimer’s….the changes overlap, but they are not identical.”

His team is now studying brain imaging and biomarkers to understand the link between COVID-related cognitive decline and traditional neurodegenerative diseases like Alzheimer’s disease.

Dr. de Erausquin also explains how persistent loss of smell — a hallmark COVID symptom — may be the strongest predictor of ongoing cognitive issues, and how genetic sequencing is helping uncover inherited risk.

He highlights a dual reality: while many Long COVID patients show biological changes, others had prior diagnoses of depression, anxiety, or chronic fatigue — a nuance often missing from public conversations.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Skin cancer is the most common cancer in the United States, and melanoma is its deadliest form. Cases have tripled in the past 30 years, particularly among younger people — even as rates for other common cancers have gone down.

Marc Hurlbert, Ph.D., CEO of the Melanoma Research Alliance (MRA), joins “Conversations on Health Care” hosts Mark Masselli and Margaret Flinter to talk about the urgent need for more research, the role of philanthropy, and why early detection remains critical.

“We’ve invested in research that’s led to 17 FDA-approved treatments, dramatically improving patient outcomes — and the dermatologist remains one of our strongest allies,” Hurlbert shares.

He also discusses the promise of cutting-edge tools like gene-based blood tests and machine learning, while calling for broader access to clinical trials.

“I think we’re at a place where philanthropy is doing more to advance research than the government,” he says.

From innovative treatment approaches to the push for inclusive prevention efforts across all communities, this conversation offers critical insights during Melanoma and Skin Cancer Awareness Month.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A recent survey surprisingly found only 41% of physicians were “very confident” about their ability to provide equal quality care to patients with a disability. Megan Morris, Ph.D., and her allies are trying to figure out why and how to boost that percentage.

STAT News’ STATUS List recently added Morris to its prestigious collection of influencers because of her role as founder of the Disability Equity Collaborative.

In an interview with “Conversations on Health Care” hosts Mark Masselli and Margaret Flinter, Morris discusses how outdated attitudes, inaccessible equipment, and a lack of training continue to limit healthcare access for patients with disabilities.

Morris also shares how new federal standards are pushing healthcare systems to better track and respond to disability needs and why simply collecting data isn’t enough without systemic change.

“We have long argued that collecting disability status information should be part of standard demographics. Just like asking what language you speak, you have to ask: ‘Do you have a disability?’ so you can identify accommodation needs early and deliver better care.”

From bias in provider attitudes to practical solutions using technology, Morris lays out a clear roadmap for building a healthcare system that truly serves everyone.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The U.S. healthcare system could save up to 500,000 lives and $1.5 trillion a year by embracing the right technology, says Dr. Robert Pearl, a Stanford University professor and a noted healthcare influencer.

Pearl, who co-authored his new book “ChatGPT, MD” with the help of generative AI, says the tech’s strength lies in its access to the entirety of medical knowledge. “We shouldn't think of [generative AI] as just another AI tool. This is as … different from what's come before as the iPhone was from the telephone that was in most people's kitchens attached to the wall.”

For clinicians and patients alike, that access can be transformative. Parents might use it to uncover what’s wrong with their child when traditional medicine is still searching for answers. A doctor might identify rare diagnoses in minutes, work that would have taken days in a library.

Hospitals already collect massive data — about a terabyte per facility annually — but 97% of it is never reviewed, Pearl says. The key is narrowing it to specific diseases or trends.

Pearl tells “Conversations on Health Care” hosts Mark Masselli and Margaret Flinter that Gen AI will gain widespread medical acceptance when studies compare outcomes with and without the technology

“We're going to find that the technology is 10% better than the average clinician … or the average nurse in a chronic disease management program…or, for that matter, potentially even the average physician doing inpatient care when there are five or six different doctors taking care of the same patient and they're not effectively communicating.”

Click now to hear his take on the technology’s other benefits.

Learn more about your ad choices. Visit podcastchoices.com/adchoices

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Eccentric billionaire Howard Hughes founded his eponymous Medical Institute over 70 years ago devoted to “unlocking the fundamentals of biology and building an open, inclusive future for science.”

Some say Howard Hughes Medical Institute is bringing its founder’s vision into the future with its one-of-a-kind Janelia Research Campus in Ashburn, Virginia. On this 281-acre parcel of land, integrated teams of lab scientists and tool-builders pursue a small number of scientific questions with potential for transformative impact. To drive science forward, they share their methods, results, and tools with the scientific community.

Nelson Spruston, Ph.D., the executive director at HHMI’s Janelia research campus, also tells hosts Mark Masselli and Margaret Flinter about AI@HHMI, its new $500 million initiative to embed AI systems throughout every stage of the scientific process.

Spruston says, “Our approach is to identify people who have a very strong track record of making important discoveries in biomedical research and letting them pursue their best ideas without asking for our permission. What we're trying to do at HHMI is to use the deep bench of talent … to come up with ideas for problems [and address] long-standing open questions in the biological sciences.”

Learn more about your ad choices. Visit podcastchoices.com/adchoices

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.